We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Feedback Plc | LSE:FDBK | London | Ordinary Share | GB00BJN59X09 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 19.80 | 19.60 | 20.00 | 19.80 | 19.80 | 19.80 | 80,955 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Electronic Computers | 1.18M | -3.3M | -0.0753 | -2.63 | 8.68M |
Date | Subject | Author | Discuss |
---|---|---|---|
13/2/2023 13:20 | Well knock me down wiv a fevver! If it ain’t my old mate from jus days. I’ll let you know when I’ve added. Your shirt should be safe here at these levels 😂. | ducatiman | |
13/2/2023 13:11 | I’m with you ducatiman I will be buying into a retrace too. | dibs61 | |
13/2/2023 12:49 | Ducatiman - would you like me to buy some? That would help a retrace I'm sure. | gowise | |
13/2/2023 12:26 | The chart is screaming retrace. That would suit me as I would be in for a few more. It’s not happening quickly though. | ducatiman | |
13/2/2023 09:34 | Trading volume picking up in the last few sessions/ weeks. | brasso3 | |
13/2/2023 08:56 | SP up another 10% in the first hour of trading. Do you think it’s trying to tell us something? ;) | dibs61 | |
12/2/2023 16:53 | 'Ctrl + F' then type 'Bleepa' in dropdown box. 6 references found - page 7 (4 refs) & 28 (2 refs). | lr2 | |
12/2/2023 16:37 | Help me out LR2 while I watch England stumble to a victory over the mighty Azzurri, where exactly? | ducatiman | |
12/2/2023 16:31 | Courtesy of Vascular over on the other place. Yorkshire & Humber AHSN - Bleepa gets a mention. | lr2 | |
12/2/2023 16:01 | As we have known for some time Ged, the clinicians love it. Getting their management to pay for it has been the issue. It looks, however, that this is about to change. | ducatiman | |
12/2/2023 12:08 | Checking the website today there seem to be a number of updates. This was in the 'News' section last Monday. For anyone looking in it summarises what Bleepa does. The link also includes some benefits. "Bleepa is simple to deploy, cost-effective and aids existing workflows, without requiring teams to reconfigure the way that they work. A former NHS Trust Chief Executive puts it simply: “Having ready, secure access to relevant data around a patient’s step-down care means you can accelerate discharge planning, minimise risks to patient safety and reduce costly, avoidable readmissions.” Thousands of care professionals have already seen the benefit that Bleepa can have in their ability to work seamlessly across care settings, ensure the highest levels of safety and care for their patients, and efficiently manage care pathways. As the only UKCA accredited medical app that allows you to share, annotate and discuss clinical grade images on a mobile device, Bleepa can help you to make the most of your team’s capacity to provide high-quality, networked care." | ged5 | |
11/2/2023 12:08 | Looking at some of the statements over on LSE, it needs pointing out that the options DO NOT EXPIRE in May 2025. They expire for Tom and Anesh in 2030 and for Rory in 2032. The share price needs to reach £2.40 by may 2025 for one third to vest, £3.72 for another third to vest and £6.00 for the final 139,744 options to vest. When the price has gone above £2.40 TO could convert 139,744 options at £1.40. It would only cost him £195,641. He has until 31st May 2030 to save up. There are a total of 1,086,703 share options. 726,186 subject to the above conditions. But of course I'm only posting what you already know because you'll all have read the annual report pages 44 and 72 and RNS 23rd February. The cheapest options for TO are £2.18. With the price at £1.65 perhaps he should get some now. Seems like a bargain for him. No advice intended. I'm not qualified to give it. | ged5 | |
10/2/2023 18:03 | LR210 Feb '23 - 14:45 - 10703 of 10710 Red Leg Rum, Yump. Best you can find on the supermarket shelves. Rum punch is a bit of a weakness. I'd like to be around long enough to see FDBK succeed, so I might give that a miss ! | yump | |
10/2/2023 16:15 | Some easy listening for Fdbk shareholders over the weekend. | ducatiman | |
10/2/2023 16:05 | Auto bid 163.50 and still in size. | ducatiman | |
10/2/2023 15:18 | Interesting read the medical technology strategy. Come on Mr Barclay get Bleepa rolled out nationwide. Right time/place certainly applies here. | petekand | |
10/2/2023 14:52 | Brasso You’ll have to be mumbling mad to sell any Feedback when the pipeline has groundbreaking news ready to churn out. I’ll stick with my prediction of nearer to £3 by the time we see the QVH RNS and that will be the key which alerts the wider market. | petekand | |
10/2/2023 14:47 | I'm holdong for 2000p Duc. | lr2 | |
10/2/2023 14:46 | I think 200 easy next week with or without news. | ducatiman | |
10/2/2023 14:45 | Red Leg Rum, Yump. Best you can find on the supermarket shelves. | lr2 | |
10/2/2023 14:34 | Crikey I feel like having a drink to celebrate ! | yump | |
10/2/2023 14:02 | Contracts news in the next 6-8 weeks should cover 200p quite well. | lr2 | |
10/2/2023 13:42 | Its hard to see why anyone would sell here with a large part of the market cap. covered by cash. Looks like a safe bet for 200p in the next 4 - 6 weeks. | brasso3 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions